NCT00158457View on ClinicalTrials.gov

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

December 31, 2006

Conditions
HIV Infection
Interventions
DRUG

Tenofovir (TDF)

DRUG

Emtricitabine (FTC)

DRUG

Efavirenz (EFV)

Trial Locations (2)

Unknown

Centre de Traitement Ambulatoire, CHU de Fann, Dakar

Service des Maladies Infectieuses, CHU de Fann, Dakar

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

OTHER

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00158457 - Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) | Biotech Hunter | Biotech Hunter